Published in
Elsevier, Clinical Lymphoma, Myeloma and Leukemia, (22), p. S310, 2022
DOI: 10.1016/s2152-2650(22)01406-9
Links
Tools
MDS-353 Clinical Outcome of Myelodysplastic Syndrome Progressing on Hypomethylating Agents With Evolving Frontline Therapies: Continued Challenges and Unmet Needs
Journal article published in 2022 by
Ahmad Ghorab 
,
Aref Al-Kali,
Michelle Elliot,
Naseema Gangat,
Hasan Alkhateeb,
Mithun Shah,
Cecilia Arana Yi,
Hemant Murthy,
Mohamed Kharfan Dabaja,
Ayalew Tefferi,
Mrinal Patnaik,
Mark Litzow,
Talha Badar
,
Aref Al-Kali,
Michelle Elliot,
Naseema Gangat,
Hasan Alkhateeb,
Mithun Shah,
Cecilia Arana Yi,
Hemant Murthy,
Mohamed Kharfan Dabaja,
Ayalew Tefferi,
Mrinal Patnaik,
Mark Litzow,
Talha Badar
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 